Continuous Decline of Toxoplasma gondii Seroprevalence in Hospital: A 1997–2014 Longitudinal Study in Paris, France

Background: The protozoan Toxoplasma gondii presents a risk for reactivation of latent cysts in immunocompromised patients. Anti-T. gondii antibodies are therefore usually screened before chemotherapy or transplantation to propose prophylactic measures against this parasite. We analyzed the results...

Descripción completa

Detalles Bibliográficos
Autores principales: Guigue, Nicolas, Léon, Lucie, Hamane, Samia, Gits-Muselli, Maud, Le Strat, Yann, Alanio, Alexandre, Bretagne, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182058/
https://www.ncbi.nlm.nih.gov/pubmed/30344515
http://dx.doi.org/10.3389/fmicb.2018.02369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182058/
https://www.ncbi.nlm.nih.gov/pubmed/30344515
http://dx.doi.org/10.3389/fmicb.2018.02369

Ejemplares similares